Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Dyslipidemia and lipid management in HIV-infected patients Lo JCurr Opin Endocrinol Diabetes Obes 2011[Apr]; 18 (2): 144-7PURPOSE OF REVIEW: Dyslipidemia is highly prevalent among patients living with chronic HIV infection and may confer increased risk of cardiovascular disease in this patient population. This review summarizes recent data investigating lipid abnormalities and its management in HIV-infected patients. RECENT FINDINGS: Studies in the last year have evaluated the effects of various lipid-lowering therapies not previously investigated in the HIV patient population. Rosuvastatin is a potent statin that appears to be well tolerated and effective in HIV-infected patients with hypercholesterolemia. SUMMARY: Dyslipidemia is common in HIV-infected individuals. Medical therapy of lipid disorders needs to take potential drug-drug interactions of lipid-lowering medications and antiretroviral agents into consideration.|Anti-HIV Agents/adverse effects/*therapeutic use[MESH]|Biomarkers/blood[MESH]|Drug Interactions[MESH]|Dyslipidemias/blood/*drug therapy/epidemiology/etiology[MESH]|Evidence-Based Medicine[MESH]|HIV Infections/complications/*drug therapy/epidemiology[MESH]|Humans[MESH]|Hypolipidemic Agents/adverse effects/*therapeutic use[MESH]|Lipids/*blood[MESH]|Risk Assessment[MESH]|Treatment Outcome[MESH] |